Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease.
about
Patients' needs, satisfaction, and health related quality of life: towards a comprehensive modelTesting the performance of the ENRICHD Social Support Instrument in cardiac patientsThe MacNew Heart Disease health-related quality of life instrument: a summaryOccurrence of symptoms and depressive mood among working-aged coronary heart disease patientsQuality of life in patients with coronary heart disease-I: assessment toolsWomen with coronary artery disease report worse health-related quality of life outcomes compared to menAdaptation of the MacNew quality of life questionnaire after myocardial infarction in an Iranian populationSymptomatic relief precedes improvement of myocardial blood flow in patients under spinal cord stimulationWomen and Chest Pain: Recognizing the Different Faces of Angina in the Emergency DepartmentTools for assessing quality of life in cardiology and cardiac surgeryA randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserveQuality-of-Life measures for cardiac surgery practice and research: a review and primerChina Patient-centered Evaluative Assessment of Cardiac Events Prospective Study of Acute Myocardial Infarction: Study Design.Standardizing disease-specific quality of life measures across multiple chronic conditions: development and initial evaluation of the QOL Disease Impact Scale (QDIS®).One-year health status outcomes of unstable angina versus myocardial infarction: a prospective, observational cohort study of ACS survivorsSex differences in perceived stress and early recovery in young and middle-aged patients with acute myocardial infarctionStandardized Outcome Measurement for Patients With Coronary Artery Disease: Consensus From the International Consortium for Health Outcomes Measurement (ICHOM)Measuring the health related quality of life of people with ischaemic heart disease.Coronary revascularisation outcome questionnaire (CROQ): development and validation of a new, patient based measure of outcome in coronary bypass surgery and angioplastyA modified regimen of extracorporeal cardiac shock wave therapy for treatment of coronary artery disease.Psychodynamic Motivation and Training program (PMT) for the secondary prevention in patients with stable coronary heart disease: study protocol for a randomized controlled trial of feasibility and effectsWhat proportion of patients refuse consent to data collection from their records for research purposes?C-reactive protein and ischemia in users and nonusers of beta-blockers and statins: data from the Heart and Soul Study.Impaired Health Status, Psychological Distress, and Personality in Women and Men With Nonobstructive Coronary Artery Disease: Sex and Gender Differences: The TWIST (Tweesteden Mild Stenosis) Study.Using multiple imputation to deal with missing data and attrition in longitudinal studies with repeated measures of patient-reported outcomesIs B-type natriuretic peptide a useful screening test for systolic or diastolic dysfunction in patients with coronary disease? Data from the Heart and Soul Study.The impact of diabetes on one-year health status outcomes following acute coronary syndromes.Quality of life and economic outcomes with surgical ventricular reconstruction in ischemic heart failure: results from the Surgical Treatment for Ischemic Heart Failure trial.Randomised controlled trial of a secondary prevention program for myocardial infarction patients ('ProActive Heart'): study protocol. Secondary prevention program for myocardial infarction patientsA mobile phone-based care model for outpatient cardiac rehabilitation: the care assessment platform (CAP).Chronic stable angina is associated with lower health-related quality of life: evidence from Chinese patients.Posttraumatic stress disorder and health-related quality of life in patients with coronary heart disease: findings from the Heart and Soul Study.Conversion of the Seattle Angina Questionnaire into EQ-5D utilities for ischemic heart disease: a systematic review and catalog of the literature.A review of health utilities using the EQ-5D in studies of cardiovascular disease.Phosphodiesterase type 5 inhibition may reduce diastolic function in women with ischemia but no obstructive coronary artery disease.Effects of on- and off-pump coronary artery surgery on graft patency, survival, and health-related quality of life: long-term follow-up of 2 randomized controlled trialsStudy protocol: a randomised controlled trial investigating the effect of exercise training on peripheral blood gene expression in patients with stable angina.Rationale and design of the Randomized Evaluation of patients with Stable angina Comparing Utilization of noninvasive Examinations (RESCUE) trial.Aldosterone inhibition and coronary endothelial function in women without obstructive coronary artery disease: an ancillary study of the national heart, lung, and blood institute-sponsored women's ischemia syndrome evaluation.Improvement of Subjective Well-Being by Ranolazine in Patients with Chronic Angina and Known Myocardial Ischemia (IMWELL Study)
P2860
Q24792040-BEA44A6B-A8F3-4FD0-AEC7-A07CBDFBED88Q24796558-AF58317D-91E2-4C8E-A3E5-4A3D7351651CQ24796818-1792CE70-C2E6-4807-B636-77522E5B0047Q24800131-EDD64668-7647-45CC-8955-76350D64624AQ24801733-8F8865E3-A930-4059-8861-7CEB9416575EQ24806980-E46336D6-8C40-412B-B4CA-B49E34EB542EQ24807008-3158DDF5-7986-4061-85EB-147ADD23C03DQ24815880-8704A110-A5E7-4E12-8924-B09FF1A26F57Q26746172-5815DC13-1CFA-4AD2-9AB0-5D08891FF462Q26747022-682AFC44-49DC-4FD5-A2A1-B9B02940F1FFQ26776330-16C1D375-A379-4FD1-99D3-D27C945B4AAEQ27015844-ADF1A59C-51EC-4909-8938-16603A0434E2Q27302208-D03BC693-C8CE-41CF-BD6D-E4531FD5C3E2Q27303937-72C681B4-B7EC-40E3-BFFB-522E3FE7B8D8Q28221394-149EDD71-A1BA-44CC-89D3-3F94EB47CFF6Q28394286-2D90A557-3E87-4280-B3A6-BDEC629349E1Q28606596-0637CC01-B454-4E61-B9A5-76FB9A5B069BQ30478673-2DF06117-6E1F-41BD-B707-D8E96921203BQ30478764-68A210CC-2503-4E45-8ABE-7FE036FC1C61Q30531411-6F6E3F97-3FA6-41E8-AAF0-27AD4AA6D09AQ30557010-1460157D-647A-44B2-9F04-B71BB8249A38Q30617956-572F1C3B-F3BF-48AC-B5FE-B0F11D2515FDQ30763122-D8FEE1AB-CF20-42FA-A278-103539FC1B85Q30840466-8BA243B1-0217-4C70-A6AF-AAC416554F04Q30887879-08A4636D-A0C6-452F-99A6-359187C97442Q30919400-A4F5A330-1072-4B6A-9901-6FD2C4FC25AEQ33261415-840C2173-BCEB-46F7-8440-4C6F2E58C89AQ33431698-8744C5E9-764A-4353-8EF3-84011173EA75Q33441975-1BB6448F-9D2E-4F47-85CB-20279B979028Q33527124-64442604-387C-4B2F-9436-ACDD9C506DD1Q33631727-6E99E3E6-E2C0-497D-8ED9-576297EF7B91Q33657031-3C48C374-BBB6-40FB-9210-84C953146F2BQ33669496-3D73D864-6112-42DF-B275-D8760D9A2474Q33669647-8718AD8A-A5DD-4907-BF7C-C017C621691CQ33711368-54EB3E91-3B69-4D96-A35D-8D1A5D52DAB6Q33719084-185AC234-6D4F-4971-86BA-324986326C10Q33721487-7D2C712E-6E54-42E2-A28E-CD47F54A0957Q33724340-A4C2E120-829A-412E-9A45-6E0B0AEC3A40Q33725441-AB376A80-BC77-44D6-97A6-5237EC648ED8Q33734021-A470FA74-6D10-41B0-80AB-207991D355EA
P2860
Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease.
description
1995 nî lūn-bûn
@nan
1995 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Development and evaluation of ...... e for coronary artery disease.
@ast
Development and evaluation of ...... e for coronary artery disease.
@en
Development and evaluation of ...... e for coronary artery disease.
@nl
type
label
Development and evaluation of ...... e for coronary artery disease.
@ast
Development and evaluation of ...... e for coronary artery disease.
@en
Development and evaluation of ...... e for coronary artery disease.
@nl
prefLabel
Development and evaluation of ...... e for coronary artery disease.
@ast
Development and evaluation of ...... e for coronary artery disease.
@en
Development and evaluation of ...... e for coronary artery disease.
@nl
P2093
P1476
Development and evaluation of ...... e for coronary artery disease.
@en
P2093
Dewhurst TA
McDonell M
Prodzinski J
Spertus JA
P304
P356
10.1016/0735-1097(94)00397-9
P407
P577
1995-02-01T00:00:00Z